Studying genome and molecular activities in patients is better than conventional medicine when it comes to detecting potential health problems, according to Michael Snyder, chair of the genetics department at Stanford University. But other researchers express doubts about costs and other issues. Public health news also looks at disaster preparedness, antibiotic resistant infections, drug safety in pregnant women, weedkiller and cancer, obesity and diabetes.
from Kaiser Health News http://bit.ly/2VrbyC6
May 09, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: October 25, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2D1t7ik … Read More
Booming Economy Helps Flatten Medicaid Enrollment And Limit Costs, States Report… Read More
In Days Of Data Galore, Patients Have Trouble Getting Own Medical Records… Read More
Amgen To Slash Cholesterol Drug Price By 60 Percent After Years Of Struggling To Gain Foothold In MarketThe new $5,850 a year price tag is still higher than cost-effectiveness watchdogs recommend, but it's a big drop from the original $14,000 a year. Sales never took off for the drug, in part because patients balked at the cost… Read More
HHS, Homeland Security Were Taken By Surprise When ‘Zero Tolerance’ Policy Was Implemented, Report FindsThe lack of advance notice left the agencies scrambling to deal with the increase in detained children, the Government Accountability Office report found. The report also noted that the absence of a central database for the m… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment